Corporate FinanceIncyte's Cash Pile Has Swung Between $1 Billion and $4 Billion in Three Years, and Smaller Biotechs Are Now Pricing Their Funding Against a Wobbling Tech MarketVia News Editorial Team•Nov 19, 2026